FDA begins review of Cornerstone drug candidate Published: Tue, Mar 13, 2012 CARY, N.C. — Cornerstone Therapeutics Inc. said Tuesday that the Food and Drug Administration will review its marketing application for a drug that treats low levels of sodium in the blood. Cornerstone said the FDA will make a decision on the drug candidate CRTX 80 by Oct. 29. The drug is intended to treat... Read More

Research identifies new option for sinus relief Published: Thu, Aug 4, 2011 Exciting new clinical results bring new hope for the millions of sinusitis sufferers in the U.S., who need an effective yet safe alternative for sinus relief. Results of a new controlled clinical trial show that a proprietary capsaicin-based nasal spray called Sinus Buster starts to provide sinus relief in under one... Read More

Drug Research Targets Malignant Melanoma Published: Thu, Sep 23, 2010 Advances in research and technology have come to typify American medicine. Through a focus on high technology, acute care brings many problems, but it also has allowed for some incredible breakthroughs. In a recent study released in The New England Journal of Medicine, researchers may have identified the next... Read More

Diabetes drug metformin found to reduce cancer risk Published: Thu, Sep 2, 2010 LOS ANGELES — A growing body of evidence suggests that the widely used diabetes drug metformin can reduce the risk of cancer, researchers say. A study in mice exposed to tobacco carcinogens, published Sept. 1, shows that the drug can reduce the development of lung tumors by as much as 70 percent, and results... Read More

Monthly Injection May Boost Success in Treatment of Alcoholism Updated: Tue, Jul 6, 2010 A once-monthly injection of an abstinence-promoting drug, known as Vivitrol, may help people suffering from alcoholism break the chains of addiction and reclaim their lives. Read More

One vaccine shot seen as protective for swine flu Updated: Thu, Sep 17, 2009 Defying the expectations of experts, clinical trials are showing that the new H1N1 swine flu vaccine protects with only one dose instead of two, so the vaccine supplies now being made will go twice as far as had been predicted. That means it should be possible to vaccinate — well before the flu’s expected... Read More

Women May Be More Likely to Experience EMS Delays for Heart Care Updated: Thu, Jan 29, 2009 Women who called 9-1-1 complaining of cardiac symptoms were 52 percent more likely than men to experience delays during emergency medical services’ (EMS) care, according to a report in Circulation: Cardiovascular Quality and Outcomes. The data did not reveal why women were more likely to be delayed. However,... Read More

Cancer Resources Published: Mon, Apr 28, 2008 When an Oklahoman is diagnosed with cancer, all too often the patient, friends and family turn to health care organizations outside the state. For the latest clinical trials and treatments, Oklahomans often drive south or north or any other direction but home. And while not well-known, the beeline to some of... Read More

Understanding Cancer Terminology Published: Mon, Apr 28, 2008 Acute: Symptoms or signs that begin and worsen quickly; not chronic. Adenocarcinoma: Cancer that begins in cells that line certain internal organs and that have gland-like (secretory) properties. Adjuvant therapy: Treatment given after the primary treatment to increase the chances of a cure. May include... Read More

Clinical trials Published: Mon, Apr 28, 2008 Clinical trials are often a last resort for cancer patients — yet fewer than 5 percent of adults with the disease take part in them. Clinical trials are how doctors and researchers ensure new treatments are safe and effective. They include drugs, medical devices and surgical procedures. More than 60... Read More

OU Cancer Institute gets Komen research grant Published: Tue, Oct 7, 2008 The OU Cancer Institute and the Central Oklahoma affiliate of Susan G. Komen for the Cure announced today that an OU researcher is the receipient of a three-year research grant from Susan G. Komen for the Cure that totals nearly $600,000. Wei-Qun Ding, a molecular biologist at the University of Oklahoma Health... Read More

Access health Updated: Tue, Jun 6, 2006 PARENTING P.R.I.D.E., Parents Responding to Infant Death Experience, 7 p.m. second Monday each month, Renaissance Women's Center, 238 N Midwest Blvd., Midwest City. 610-3627. Miscarriage Support Group, 7 p.m. third Tuesday, 340 SE 62. Sponsored by OKC First Friends Church. 602-1590. P.R.I.D.E., Parents Responding... Read More

Tuesday, May 30, 2006 Updated: Tue, May 30, 2006 VOLUNTEERS Heartland Hospice of Norman needs volunteers. Call Jacqueline Parker, 579-8565. Calm Waters Center for Children and Families seeks volunteers to help children deal with divorce and death. 946-2264. Frontier Hospice seeks volunteers. Call Pat McGowin, 789-2913. Community Hospice of Oklahoma seeks... Read More

New treatment extends lives of ovarian cancer patients Updated: Thu, Jan 5, 2006 Women with advanced ovarian cancer can live more than a year longer with an aggressive chemotherapy treatment tested at the University of Oklahoma Health Sciences Center. OU researchers in Oklahoma City stop short of terming the method -- "intraperitoneal" or IP chemotherapy -- a cure for ovarian cancer. But they... Read More

Experimental drug shows promise against ovarian cancer Updated: Thu, Oct 13, 2005 Ovarian cancer is one of the hardest to treat, and even if a patient does beat it there's still a chance it can come back even stronger. A new experimental drug is showing promise, and may become a powerful weapon when battling it for a second time. Read More